Receipts a bit lower than expected.
But unit sales up 50% which will flow into subsequent quarters receipts. And presumably higher margin Boosts are contributing to the growth in unit sales.
With the NHS sales starting next quarter and R&D tax rebate later in the year CRs might be a thing of the past.
Ann: Quarterly Activities Report and Appendix 4C, page-3
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| NUH (ASX) Chart |
Day chart unavailable